Zipfel Peter F
Zipfel Peter F
Leibniz Institute for Natural Product Research and Infection Biology
Bestätigte E-Mail-Adresse bei
Zitiert von
Zitiert von
Complement regulators and inhibitory proteins
PF Zipfel, C Skerka
Nature Reviews Immunology 9 (10), 729-740, 2009
Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype
M Noris, J Caprioli, E Bresin, C Mossali, G Pianetti, S Gamba, E Daina, ...
Clinical Journal of the American Society of Nephrology 5 (10), 1844-1859, 2010
Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes”(KDIGO) Controversies Conference
THJ Goodship, HT Cook, F Fakhouri, FC Fervenza, V Frémeaux-Bacchi, ...
Kidney international 91 (3), 539-551, 2017
Complement factor H binds malondialdehyde epitopes and protects from oxidative stress
D Weismann, K Hartvigsen, N Lauer, KL Bennett, HPN Scholl, PC Issa, ...
Nature 478 (7367), 76-81, 2011
Membranoproliferative glomerulonephritis type II (dense deposit disease): an update
GB Appel, HT Cook, G Hageman, JC Jennette, M Kashgarian, ...
Journal of the American Society of Nephrology 16 (5), 1392-1403, 2005
Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome
T Manuelian, J Hellwage, S Meri, J Caprioli, M Noris, S Heinen, M Jozsi, ...
The Journal of clinical investigation 111 (8), 1181-1190, 2003
Hypocomplementemia discloses genetic predisposition to hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: role of factor H abnormalities
Journal of the American Society of Nephrology 10 (2), 281-293, 1999
Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency
M Józsi, C Licht, S Strobel, SLH Zipfel, H Richter, S Heinen, PF Zipfel, ...
Blood, The Journal of the American Society of Hematology 111 (3), 1512-1514, 2008
Deletion of Complement Factor H–Related Genes CFHR1 and CFHR3 Is Associated with Atypical Hemolytic Uremic Syndrome
PF Zipfel, M Edey, S Heinen, M Józsi, H Richter, J Misselwitz, B Hoppe, ...
PLoS genetics 3 (3), e41, 2007
Factor H–related protein 1 (CFHR-1) inhibits complement C5 convertase activity and terminal complex formation
S Heinen, A Hartmann, N Lauer, U Wiehl, HM Dahse, S Schirmer, ...
Blood, The Journal of the American Society of Hematology 114 (12), 2439-2447, 2009
Immune evasion of Borrelia burgdorferi by acquisition of human complement regulators FHL‐1/reconectin and Factor H
P Kraiczy, C Skerka, M Kirschfink, V Brade, PF Zipfel
European journal of immunology 31 (6), 1674-1684, 2001
Complement factor H is a serum-binding protein for adrenomedullin, and the resulting complex modulates the bioactivities of both partners
R Pıo, A Martı́nez, EJ Unsworth, JA Kowalak, JA Bengoechea, PF Zipfel, ...
Journal of Biological Chemistry 276 (15), 12292-12300, 2001
Factor H family proteins and human diseases
M Józsi, PF Zipfel
Trends in immunology 29 (8), 380-387, 2008
New approaches to the treatment of dense deposit disease
RJH Smith, J Alexander, PN Barlow, M Botto, TL Cassavant, HT Cook, ...
Journal of the American Society of Nephrology 18 (9), 2447-2456, 2007
The molecular basis of familial hemolytic uremic syndrome: mutation analysis of factor H gene reveals a hot spot in short consensus repeat 20
J Caprioli, P Bettinaglio, PF Zipfel, B Amadei, E Daina, S Gamba, ...
Journal of the American Society of Nephrology 12 (2), 297-307, 2001
Mapping of the complement regulatory domains in the human factor H-like protein 1 and in factor H1.
S Kühn, C Skerka, PF Zipfel
Journal of immunology (Baltimore, Md.: 1950) 155 (12), 5663-5670, 1995
Factor H family proteins: on complement, microbes and human diseases
PF Zipfel, C Skerka, J Hellwage, ST Jokiranta, S Meri, V Brade, P Kraiczy, ...
Biochemical Society Transactions 30 (6), 971-978, 2002
Atypical aHUS: state of the art
CM Nester, T Barbour, SR de Cordoba, MA Dragon-Durey, ...
Molecular immunology 67 (1), 31-42, 2015
Synthesis of the CC-chemokines MIP-1alpha, MIP-1beta, and RANTES is associated with a type 1 immune response.
S Schrum, P Probst, B Fleischer, PF Zipfel
Journal of immunology (Baltimore, Md.: 1950) 157 (8), 3598-3604, 1996
C3 glomerulopathy—understanding a rare complement-driven renal disease
RJH Smith, GB Appel, AM Blom, HT Cook, VD D’Agati, F Fakhouri, ...
Nature reviews nephrology 15 (3), 129-143, 2019
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20